Role of the sympathetic nervous system in regulating renin and aldosterone production in man

The Journal of Clinical Investigation
R D GordonD P Island

Abstract

Several lines of evidence have been developed indicating that the sympathetic nervous system may play a role in mediating the renal and adrenocortical secretory responses to upright posture and sodium deprivation. Despite concurrent increases in arterial blood pressure, the plasma renin activity of normal subjects increased both in response to the infusion of catecholamines (norepinephrine: epinephrine, 10:1) and in response to stimulation of the sympathetic nervous system by cold. Aldosterone excretion was also increased by catecholamine infusion. In normal subjects the stimuli of upright posture and of sodium depletion both resulted in increases in urinary catecholamines, plasma renin activity, and urinary aldosterone. A patient with severe autonomic insufficiency did not experience normal elevations of urinary catecholamines, plasma renin activity, or urinary aldosterone in response to upright posture or sodium deprivation, despite a substantial fall in arterial blood pressure. When orthostatic hypotension was prevented by infusion of catecholamines, however, increases in plasma renin activity and in aldosterone excretion were observed. We suggest that both upright posture and sodium depletion lead to decreases in effective ...Continue Reading

References

Nov 1, 1966·The Journal of Clinical Endocrinology and Metabolism·L K WolfeG W Liddle
Oct 1, 1966·The Journal of Clinical Investigation·R D GordonG W Liddle
Jan 1, 1967·The Journal of Clinical Endocrinology and Metabolism·P E Slaton, E G Biglieri
Oct 1, 1966·Circulation Research·R D BunagJ W McCubbin
Dec 1, 1954·Proceedings of the Society for Experimental Biology and Medicine·J A LUETSCHER, B J AXELRAD
Sep 1, 1956·The American Journal of Medicine·F C BARTTERG W LIDDLE
May 1, 1960·Circulation·F C BARTTER, D S GANN
Mar 31, 1959·Acta Physiologica Scandinavica·U von EULER, F LISHAJKO
Nov 1, 1961·The Journal of Clinical Investigation·C C CARPENTERC R AYERS
Jul 1, 1964·Circulation Research·S L SKINNERI H PAGE
Aug 1, 1964·The Journal of Clinical Endocrinology and Metabolism·T BLEDSOEG W LIDDLE

❮ Previous
Next ❯

Citations

Oct 1, 1973·European Journal of Clinical Pharmacology·A SlabýR Reisenauer
Nov 1, 1985·Medical & Biological Engineering & Computing·R J UttamsinghL Finkelstein
Oct 26, 2012·Pflügers Archiv : European journal of physiology·Mads DamkjærPeter Bie
Apr 1, 1972·The American Journal of Cardiology·J R Caldwell, O A Carretero
Dec 1, 1977·The American Journal of Medicine·A M ChonkoT F Ferris
Jun 1, 1971·Journal of Psychiatric Research·M S AronoffJ Durell
Jan 1, 1994·Physiology & Behavior·T YoshidaT Morimoto
Jan 1, 1980·Pharmacology & Therapeutics·W H Birkenhäger, P W de Leeuw
Jan 1, 1978·General Pharmacology·W S Peart
Jul 20, 2002·Journal of the Neurological Sciences·Samir M ParikhDavid Robertson
May 1, 1990·Journal of the American College of Cardiology·M W KronenbergD Robertson
Sep 1, 1969·The Journal of Physiology·J R Blair-West, A H Brook
Nov 6, 2013·Nature Reviews. Nephrology·Kazuomi Kario
Jun 18, 1970·The New England Journal of Medicine·L ShearG J Gabuzda
Oct 29, 1970·The New England Journal of Medicine·M H Leidner
May 23, 2002·Clinical Neuropharmacology·Horacio Kaufmann
May 1, 1997·Journal of Clinical Neurophysiology : Official Publication of the American Electroencephalographic Society·H Kaufmann
Dec 1, 1978·Clinical and Experimental Dermatology·E M Saihan, R R Harman
Mar 1, 1984·Clinical and Experimental Pharmacology & Physiology·K HiramatsuM Katakura
May 1, 1971·Australian and New Zealand Journal of Medicine·J P CoghlanR D Wright
Apr 1, 1973·Australian and New Zealand Journal of Medicine·M D Esler, P J Nestel
Jun 1, 1974·Australian and New Zealand Journal of Medicine·R Vandongen
May 1, 1982·Journal of Neurology, Neurosurgery, and Psychiatry·G Galassi
Jan 1, 1973·Postgraduate Medical Journal·G M Yuill
Aug 25, 2011·American Journal of Physiology. Endocrinology and Metabolism·Annette D de KloetStephen C Woods
Jul 1, 1970·The Journal of Clinical Investigation·M A DiamondP G Schmid
Jul 15, 1978·Klinische Wochenschrift·F H MesserliM H Maxwell
Jan 1, 1984·Clinical and Experimental Hypertension. Part A, Theory and Practice·M G NichollsP J Bones
Feb 1, 1974·Scandinavian Journal of Clinical and Laboratory Investigation·R KalaA Eisalo
Jan 1, 1982·Clinical and Experimental Hypertension. Part A, Theory and Practice·A Gillies, T Morgan
Jan 1, 1985·The American Journal of the Medical Sciences·O KuchelJ Genest
Jan 1, 1973·Kidney International·W G Walker, C R Cooke
Nov 1, 1975·Kidney International·P WeidmannJ de Lima

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Circulation Research
R D BunagJ W MCCUBBIN
British Medical Journal
E J LewisR Hickler
The New England Journal of Medicine
M D BlaufoxJ P Merrill
© 2021 Meta ULC. All rights reserved